Tag: suppurativa
Novartis: approval in hidradenitis suppurativa
(CercleFinance.com) – Novartis announces that the United States FDA has approved its Cosentyx (secukinumab) for the treatment in adults of moderate to severe forms of hidradenitis suppurativa, a chronic skin…
Novartis: Positive Data in Hidradenitis Suppurativa
Receive the value of the day selected by The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its…
Novartis: positive data in hidradenitis suppurativa
(CercleFinance.com) – During a last-minute presentation at the 31st Congress of the European Academy of Dermatology and Venereology (EADV), Novartis announces positive results from two pivotal phase III studies (SUNSHINE…